chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Road traffic accident, X-ray limb, X-ray of pelvis and hip
Clinical narrative: This serious spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 730597), concerning a 46-year-old, adult, female patient. On an unspecified date, the patient's nuclear magnetic resonance imaging (MRI) contrast was performed. The patient's current conditions included hypothyroidism, diabetes, high blood pressure (reported as medical history), cervical bulging discs, toothache and dry socket. The patient was allergic to sulfa drugs, CIPRO, tetracycline, excessive lidocaine, pecan, tomatoes, oranges and latex (since an unspecified date). The patient's concomitant medications included levothyroxine and DHEA for unknown indications. It was reported that on 11-Dec-2017, the patient went to hospital to collect MRI result (unspecified) and was unexpectedly administered FLUVIRIN (dose: 0.5 ml, route of administration: injection [SYR as reported], anatomical location: arm, batch number and expiry date: not reported). On the same day (11-Dec-2017), at about 11:15 AM,  when the patient was driving, she had an intense itching at the injection site in the shoulder. The patient felt that injected arm was entirely on fire (as reported) and burning. Later, the patient had passed out and then car ran off the road, hit an embankment, the car went airborne (as reported) and the patient rolled over for several times in the car. The patient was taken by air evacuation to the nearest hospital. It was reported that, the patient was administered Td vaccine. On an unspecified date, the patient had undergone complete blood count (CBC) with differential white blood cell count, comprehensive metabolic function tests, computed tomography (CT) for head and cervical spine, X-ray for chest, shoulder, pelvis and hip were performed, the results of all the tests were not reported. At the time of this report, the patient had not recovered from the events (passed out, injection site itching, burning sensation and road traffic accident).
Sex: M
Vaccine: FLUX
Symptoms: Chills, Fatigue, Headache, Insomnia, Pain
Clinical narrative: This is spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730611), concerns a 49-year-old, adult, male patient. The patient did not have any medical history. The patient was on Prep at the time of vaccination. On 05-Dec-2017, the patient was administered influenza vaccine (dose: unk as reported, route of administration: injection [SYR as reported], anatomical location: left arm, batch number, trade name, manufacturer: not reported). On 14-Dec-2017, 9 days after vaccination (over a week), the patient experienced extreme headache in the morning. As the day passed by, the patient felt body ache and tiredness. In the night, the symptoms became severe, the patient had high fever and chills. The patient received ADVIL after which the symptoms were improving. Eventually, the fever went away, but headache persisted. It was reported that, the patient was not able to sleep due to headache. At the time of this report, the outcome of the events was unknown. The reporter considered the event as non-serious. Update 11-Jul-2018: Case correction was performed with IRD 06-Jun-2018: As determined causality of the events was corrected from related to not related. The case comment was corrected accordingly.
Sex: M
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: This is spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730611), concerns a 49-year-old, adult, male patient. The patient did not have any medical history. The patient was on Prep at the time of vaccination. On 05-Dec-2017, the patient was administered influenza vaccine (dose: unk as reported, route of administration: injection [SYR as reported], anatomical location: left arm, batch number, trade name, manufacturer: not reported). On 14-Dec-2017, 9 days after vaccination (over a week), the patient experienced extreme headache in the morning. As the day passed by, the patient felt body ache and tiredness. In the night, the symptoms became severe, the patient had high fever and chills. The patient received ADVIL after which the symptoms were improving. Eventually, the fever went away, but headache persisted. It was reported that, the patient was not able to sleep due to headache. At the time of this report, the outcome of the events was unknown. The reporter considered the event as non-serious. Update 11-Jul-2018: Case correction was performed with IRD 06-Jun-2018: As determined causality of the events was corrected from related to not related. The case comment was corrected accordingly.
Age: 49.0
Sex: M
Vaccine: FLUX
Symptoms: Arthritis, Laboratory test, Pain, Vaccination complication
Clinical narrative: This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730760), concerns a 49-year-old, adult, male patient. The patient's historical condition included leg vein issues. The patient's current condition included high blood pressure (since an unspecified date). The patient's concomitant medication included fish oil with vitamin D. The patient had no history of allergies. On 05-Oct-2017, the patient was administered INN Flu Vaccine Seasonal (dose: reported as 1st dose, route of administration: subcutaneous, anatomical location: right arm, batch number, expiry date, trade name, manufacturer: not reported) at work. On 08-Oct-2017, 3 days after vaccination, in the night, the patient experienced soreness and aches (reported as achy) across the body. On the following day, the patient felt something wrong (as reported) and went to the emergency room. The doctor ignored the symptoms and diagnosed with knee arthritis. Later, in the same week, the patient consulted the doctor again and diagnosed with a bad reaction to the flu vaccine. The patient was referred to a rheumatologist, as the vaccine seemed to have triggered arthritis. It was reported that, the patient underwent several tests (unspecified), but did not have the data. At the time of this report, the patient had not yet recovered form he events. The reporter assessed the case as non-serious. Update 11-Jul-2018: Non-significant cast correction received with IRD 06-Jun-2018: The case comment was corrected.
Age: 71.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Asthenia, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: This spontaneous case, reported by Pharmacist via company representative to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731002), concerns a 71-year-old, elderly, female patient. The patient's historical conditions, current conditions, allergies and concomitant medications were not reported. On an unspecified date in Oct-2017, the patient was administered with influenza vaccine (dose: high dose, anatomical location: arm (unspecified arm), route of administration, batch number, expiry date, manufacturer and trade name: not reported) and non-company suspect product PNEUMOVAX 23 (dose: 1 DF (reported as one shot), anatomical location: arm (unspecified arm), route of administration, batch number and expiry date: not reported). It was reported that, both vaccines were administered in the same arm, but it was unknown, whether both vaccines were administered in the left arm or right arm. On an unspecified date in 2017, after vaccination, the patient experienced feeling of weakness, achiness with redness and painful swelling at the injection site. The patient received an unspecified treatment but was not hospitalized for the events. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 62.0
Sex: F
Vaccine: FLUX
Symptoms: Ear discomfort, Erythema, Erythema of eyelid, Ocular hyperaemia, Skin warm
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731080), concerns a 62-year-old, adult, female patient. On 13-Dec-2014, when patient was 60-year-old, she was administered with ZOSTAVAX for both shingles and experienced skin warm, swelling, tenderness and urticaria. On an unspecified date in Dec-2016, the patient administered with right eye shingles for which the patient still treated with drops and pills. The patient's current condition included asthma, elevated blood pressure, diabetes, right eye shingles and lip herpes (since an unspecified date) and allergies included bees, latex bandages, erythromycin, sulfa medicines, retinoids and tretinoin (since an unspecified date). The patient's concomitant medications included metformin, lisinopril, atorvastatin, acyclovir, acyclovir ointment, QVAR, hydrochlorothiazide, albuterol, ipratropium bromide, fluorometholone, multivitamin, iron, B12, COQ10, lutein, melatonin, fish oil, hair vitamins and basic for an unknown indication. On 28-Sep-2017, the patient was administered with influenza vaccine, (dose: 1 [as reported], route of administration: injection [SYR as reported], anatomical location: left arm, batch number and expiry date: not reported). On 29-Sep-2017, after 1 day of vaccination, the patient experienced a 3-inch-long, 1-inch-wide tapered raised welt, which was extremely hot, bright pink and swollen. The patient had reddish eyes including lower lid edges especially in her right shingles eye. The patient's cheeks became swollen especially the left side, inside the mouth, clear to the jaw line [as reported]. Later, at 01:00 PM (going in to day 3 as reported), the patient's ears were plugged up. On 03-Oct-2017, the patient's arm mark was faded, warmer than the surrounding skin and still tender to touch. On 07-Oct-2017, the patient had recovered from the events (swelling face, welts, swelling, ear congestion, skin warm, tenderness, redness of eyes and redness of eyelid). The reporter assessed this case as non-serious.
Age: 62.0
Sex: F
Vaccine: FLUX
Symptoms: Swelling, Swelling face, Tenderness, Urticaria
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731080), concerns a 62-year-old, adult, female patient. On 13-Dec-2014, when patient was 60-year-old, she was administered with ZOSTAVAX for both shingles and experienced skin warm, swelling, tenderness and urticaria. On an unspecified date in Dec-2016, the patient administered with right eye shingles for which the patient still treated with drops and pills. The patient's current condition included asthma, elevated blood pressure, diabetes, right eye shingles and lip herpes (since an unspecified date) and allergies included bees, latex bandages, erythromycin, sulfa medicines, retinoids and tretinoin (since an unspecified date). The patient's concomitant medications included metformin, lisinopril, atorvastatin, acyclovir, acyclovir ointment, QVAR, hydrochlorothiazide, albuterol, ipratropium bromide, fluorometholone, multivitamin, iron, B12, COQ10, lutein, melatonin, fish oil, hair vitamins and basic for an unknown indication. On 28-Sep-2017, the patient was administered with influenza vaccine, (dose: 1 [as reported], route of administration: injection [SYR as reported], anatomical location: left arm, batch number and expiry date: not reported). On 29-Sep-2017, after 1 day of vaccination, the patient experienced a 3-inch-long, 1-inch-wide tapered raised welt, which was extremely hot, bright pink and swollen. The patient had reddish eyes including lower lid edges especially in her right shingles eye. The patient's cheeks became swollen especially the left side, inside the mouth, clear to the jaw line [as reported]. Later, at 01:00 PM (going in to day 3 as reported), the patient's ears were plugged up. On 03-Oct-2017, the patient's arm mark was faded, warmer than the surrounding skin and still tender to touch. On 07-Oct-2017, the patient had recovered from the events (swelling face, welts, swelling, ear congestion, skin warm, tenderness, redness of eyes and redness of eyelid). The reporter assessed this case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUX
Symptoms: Dizziness, Dyspnoea
Clinical narrative: This spontaneous case, reported by  healthcare professional (other) to VAERS and initially retrieved 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731100), concerns a 65-year-old, adult, male patient. On 11-Aug-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On the same day, after vaccination, the patient experienced dizziness and dyspnoea. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Sex: M
Vaccine: FLUX, HPV9
Symptoms: Alopecia
Clinical narrative: This spontaneous case, reported by a physician to VAERS and initially retrieved on 06-Jun-2018 by Sequris from VAERS (VAERS ID: 731159), concerns a 11-year-old adolescent male patient. The patient's current conditions, concomitant medications and allergies were not reported. On 15-Aug-2016, the patient was vaccinated with the first dose of GARDASIL 9 (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported). On 17-Oct-2016, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On the same day, the patient was administered with GARDASIL 9 (dose, route of administration, anatomical location, batch number, expiry date: not reported). On 26-Sep-2017, 11 months 10 days after vaccination, the patient was diagnosed with alopecia. The outcome of the event was unknown. The reporter assessed the case as non-serious. Update 03-Jul-2018: Non-significant case correction performed with IRD 06-Jun-2018: In the case comment '2 doses' were changed to '2nd dose'.
Age: 53.0
Sex: M
Vaccine: FLUX
Symptoms: Abdominal discomfort, Burning sensation, Chest discomfort, Chest pain, Cough
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731661), concerns a 53-year-old, adult, male patient. The patient had no medical history and the patient was not taking any concomitant medications at the time of vaccination. On 15-Dec-2017, the patient was administered influenza vaccine, (dose: 1 [as reported], route of administration: injection [SYR as reported], anatomical location: right arm, batch number and expiry date: not reported). On the same day (15-Dec-2017), after vaccination, the patient felt burning sensation in the arm, shoulder and chest which became congested a few days later. On an unspecified date in Dec-2017 [reported as 2 additional days], the patient developed sore throat, cough and fever. Later, the patient observed the discharge from eyes with crusting and then swelling to eye and face. The patient also experienced rapid and strong heart rate at night with abdomen and chest discomfort. The patient went to physician. Lab investigations were not reported. At the time of the report, the patient had not recovered from the events (swelling face, burning sensation, sore throat, fever, cough, respiratory tract congestion, eye discharge, eye crusting, eye swelling, chest discomfort, abdominal discomfort, heart rate increased, heart rate abnormal). The reporter assessed this case as non-serious. Update 01-Aug-2018: Non-significant case correction performed with IRD 06-Jun-2018: All the event verbatims were made concise.
Age: 53.0
Sex: M
Vaccine: FLUX
Symptoms: Eye discharge, Eye swelling, Eyelid margin crusting, Heart rate increased, Oropharyngeal pain
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731661), concerns a 53-year-old, adult, male patient. The patient had no medical history and the patient was not taking any concomitant medications at the time of vaccination. On 15-Dec-2017, the patient was administered influenza vaccine, (dose: 1 [as reported], route of administration: injection [SYR as reported], anatomical location: right arm, batch number and expiry date: not reported). On the same day (15-Dec-2017), after vaccination, the patient felt burning sensation in the arm, shoulder and chest which became congested a few days later. On an unspecified date in Dec-2017 [reported as 2 additional days], the patient developed sore throat, cough and fever. Later, the patient observed the discharge from eyes with crusting and then swelling to eye and face. The patient also experienced rapid and strong heart rate at night with abdomen and chest discomfort. The patient went to physician. Lab investigations were not reported. At the time of the report, the patient had not recovered from the events (swelling face, burning sensation, sore throat, fever, cough, respiratory tract congestion, eye discharge, eye crusting, eye swelling, chest discomfort, abdominal discomfort, heart rate increased, heart rate abnormal). The reporter assessed this case as non-serious. Update 01-Aug-2018: Non-significant case correction performed with IRD 06-Jun-2018: All the event verbatims were made concise.
Age: 53.0
Sex: M
Vaccine: FLUX
Symptoms: Pyrexia, Respiratory tract congestion, Swelling face
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731661), concerns a 53-year-old, adult, male patient. The patient had no medical history and the patient was not taking any concomitant medications at the time of vaccination. On 15-Dec-2017, the patient was administered influenza vaccine, (dose: 1 [as reported], route of administration: injection [SYR as reported], anatomical location: right arm, batch number and expiry date: not reported). On the same day (15-Dec-2017), after vaccination, the patient felt burning sensation in the arm, shoulder and chest which became congested a few days later. On an unspecified date in Dec-2017 [reported as 2 additional days], the patient developed sore throat, cough and fever. Later, the patient observed the discharge from eyes with crusting and then swelling to eye and face. The patient also experienced rapid and strong heart rate at night with abdomen and chest discomfort. The patient went to physician. Lab investigations were not reported. At the time of the report, the patient had not recovered from the events (swelling face, burning sensation, sore throat, fever, cough, respiratory tract congestion, eye discharge, eye crusting, eye swelling, chest discomfort, abdominal discomfort, heart rate increased, heart rate abnormal). The reporter assessed this case as non-serious. Update 01-Aug-2018: Non-significant case correction performed with IRD 06-Jun-2018: All the event verbatims were made concise.
Age: 69.0
Sex: F
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Pain, Sleep disorder
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 731754), concerns a 69-year-old, elderly, female patient. The patient's current conditions included muscular pain and joint pain, osteoarthritis, high cholesterol (but resolved with meds as reported), irritable bowel syndrome [IBS] with chronic constipation, chronic pain from arthritis, restless legs syndrome, sleep apnea (but no longer using C-Pap machine, was throwing it off after couple hours of sleep). The patient's family history included heart conditions but have not been diagnosed with any. The patient was allergic to sulfa, LIPITOR, ZYRTEC, FLEXERIL, AMBIEN, NAPROSYN, TESSALON, VYTORIN. The patient's historical procedure included back surgery on 22-Sep-2017. The patient's concomitant medications included CYMBALTA, folic acid, XANAX, atenolol, simvastatin, ZETIA, Pramipexole, LINZESS, NEURONTIN, NUVIGIL, triple magnesium complex, aspirin, fish oil with omega-3 fatty acids, turmeric, calcium, calcium and vitamin D, vitamin B12, multivitamin and biotin for an unknown indication. On 07-Nov-2017, the patient was administered with influenza vaccine, (dose: 1 DF, route of administration: injection [SYR as reported], anatomical location: left arm, batch number, manufacturer and trade name was not reported). On the same day, after vaccination, within two hours, the patient experienced a throbbing pain. The patient started physical therapy for the left arm wk (as reported). It was reported that, the patient had to wake up every time when positions were changed. The patient could not raise her left arm without using the right hand, which help to raise it in the morning. It hurt when purse was carried with the right hand and use her left arm to drive. The throbbing pain was constant and that was the last week of the pain. On 12-Nov-2017, the patient consulted a primary doctor and got an advice. The patient was already on physical therapy [PT] for back surgery (22-Sep-2017). For every episode of PT, the patient had to copay. It was stated that, on 19-Dec-2017, the patient was discharged (reported as dismissed) from the neurosurgery department for the back surgery. On 08-Jan-2018, the patient also consulted orthopaedic doctor having a thought on arthritis. The doctor checked and told that it might be a shoulder hurt. At the time of this report, the patient had not yet recovered from the events. The reporter assessed this case as non-serious. Update 11-Jul-2018: Non-significant case correction received with IRD 06-Jun-2018: The abbreviation for "w/o" was changed to "without" and "w/" was changed to "with" in the narrative. The case comment was corrected.
Age: 49.0
Sex: F
Vaccine: FLUX
Symptoms: Neuralgia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 732136), concerning a 49-year-old, adult, female patient. The patient's current conditions included: diabetes mellitus, chronic pain and hypothyroid. The patient had no known drug allergies. Concomitant medications included: HUMALOG, WELLBUTRIN, NARCOTAN, morphine and SYNTHROID for an unknown indication. On 18-Dec-2017, the patient was administered influenza vaccine, (route of administration: intramuscular, anatomical location: left arm (too anterior on upper arm), dose, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date, after vaccination, the patient developed nerve pain followed by distribution to the brachial plexus. The patient made a visit to the physician's office for the events. At the time of this report, the patient had not yet recovered from the events (injection site reaction and nerve pain). The reporter assessed this case as non-serious. Update 03-Jul-2018: Significant case correction was performed with IRD 06-Jun-2018: Vaccine administration date (18-Dec-2017) was added in the narrative. The determined causality for the events (injection site reaction and nerve pain) was changed from unassessable to related. Upon internal review, it was realized that, the outcome of the event (drug administered at inappropriate site) was captured as 'not recovered' previously. Hence, it was corrected to unknown.
Sex: F
Vaccine: FLUX
Symptoms: Pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 732158), concerning a female patient of an unspecified age. The patient's medical history, current illness and concomitant medications were not reported. On an unspecified date, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date, after vaccination, the patient experienced aches and pain. Laboratory investigations and corrective treatment were not reported. At the time of this report, the outcome of the event was not reported. The reporter assessed the case as non-serious.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Facial paralysis
Clinical narrative: This is serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 17-Jul-2018 by Seqirus from VAERS (VAERS ID: 732166), concerns a 39-year-old, adult, female patient. The patient had no medical history and no known allergies. On 29-Nov-2017, the patient was administered FLUVIRIN (dose: 0.5 ml [reported as third dose], route of administration: intramuscular, anatomical location: left arm, batch number: 179905P [reported as 17990SP]). On 10-Dec-2017, 11 days after vaccination, the patient experienced paralysis on the right side of the face. On an unspecified date, the patient had an emergency room visit and office visit. The outcome of the event (paralysis of the right side of the face) was not reported.
Age: 1.08
Sex: M
Vaccine: DTAP, FLUX, HIBV, PNC13
Symptoms: Erythema, Pruritus, Skin swelling, Urticaria
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732365), concerns a 1-year-old, infant male patient (reported as 1.08). The patient's historical condition included: eczema. The patient was allergic to dog dander, egg whites, nuts, salmon, shellfish and wheat. The patient did not receive any concomitant medication. On 14-Dec-2016, the patient was administered with influenza vaccine, (route of administration: injection (reported as SYR), dose, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On the same day, the patient was administered with non-company suspect drug Dtap (route of administration: injection (reported as SYR), anatomical location: leg, dose, batch number, expiry date: not reported), Hib (route of administration: injection (reported as SYR), anatomical location: leg, dose, batch number, expiry date: not reported) and PREVNAR 13 (route of administration: injection (reported as SYR), anatomical location: leg, dose, batch number, expiry date: not reported). On the following day of vaccination (15-Dec-2016), the patient experienced severe hives that persisted for 5 months. In addition, redness, raised and severe itchy skin. The patient made a visit to the physician's office for the events. At the time of this report, the outcome of the events was unknown. The reporter assessed the case as non-serious.
Age: 51.0
Sex: F
Vaccine: FLUX
Symptoms: Influenza, Nasopharyngitis, White blood cell count decreased
Clinical narrative: This serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732596), concerns a 51-year-old adult female patient. The patient's medical history was not reported. The patient's current condition included rheumatoid arthritis. The patient's concomitant medication included KEVZARA for rheumatoid arthritis. On 01-Oct-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacture: not reported). On 10-Dec-2017, 2 months 9 days after vaccine administration, the patient experienced cold and flu symptoms. The patient thought that cold and flu symptoms were probably related to her allergies. On 13-Dec-2017, the patient consulted doctor for cold and flu symptoms. On an unspecified date (after 13-Dec-2017), the patient's white blood cell count was low for which patient was scheduled for an appointment with doctor on 28-Dec-2017. The patient's corrective treatment was not reported. At the time of this report, the patient had not recovered from the events.
Sex: F
Vaccine: FLUX
Symptoms: Flushing, Hypoaesthesia, Swelling
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732615), concerns a 27-year-old, adult female patient. On 18-Oct-2017, the patient was administered influenza vaccine (dose, route of administration, anatomical location, trade name, manufacturer: not reported). On an unspecified date, after vaccination the patient experienced numbness, swelling and flushing. At the time of report, the outcome of the events was unknown. The reporter assessed this case as non-serious. Update 19-Jul-2018: Non-significant case correction was performed with IRD 18-Jun-2018: Upon internal review it was found that, the narrative and case comment must be amended as per new update. Therefore, necessary changed were made in narrative and case comment.
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Grip strength decreased, Immediate post-injection reaction, Impaired driving ability, Muscular weakness, Paraesthesia
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732661), concerns a 29-year-old, adult female patient. The patient's current condition included: eye infection: stye/blepharitis. Concomitant medication included: cephalexin for blepharitis. The patient was sensitive to gluten. On 23-Oct-2017, the patient was administered influenza vaccine, (route of administration: injection (reported as SYR), dose, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). The patient developed weakness in her calf muscles immediately following the shot (few minutes after receiving the vaccine) and weakness in her hands a couple of hours later. She had difficulty in opening jars/grip items and difficult to even press the gas pedal. The patient could not do more than a few single leg calf raises at a time for couple of hours. The patient felt weird weakness and tingling sensation in her both calf muscles and hands. The patient had recovered from the events after six hours. The reporter assessed the case as non-serious. Update 19-Jun-2018: Non-significant case correction received with IRD 18-Jun-2018: The verbatims for all the events were corrected and minor changes were done in the narrative.
Age: 44.0
Sex: F
Vaccine: FLUX
Symptoms: Body temperature increased, Chills, Headache, Hyperhidrosis, Nasal congestion
Clinical narrative: This spontaneous case, reported by non-healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732685), concerns a 44-year-old, adult, female patient. The patient's historical condition included Hashimoto's disease. On 02-Jan-2018, the patient was administered with influenza vaccine (dose: [reported as first dose], route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On 03-Jan-2018, 1 day after vaccination, the patient experienced shivers, nausea, headache, nasal congestion and profuse sweating. The patient's temperature was found to be 102 Fahrenheit. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 44.0
Sex: F
Vaccine: FLUX
Symptoms: Nausea
Clinical narrative: This spontaneous case, reported by non-healthcare professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 732685), concerns a 44-year-old, adult, female patient. The patient's historical condition included Hashimoto's disease. On 02-Jan-2018, the patient was administered with influenza vaccine (dose: [reported as first dose], route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On 03-Jan-2018, 1 day after vaccination, the patient experienced shivers, nausea, headache, nasal congestion and profuse sweating. The patient's temperature was found to be 102 Fahrenheit. At the time of this report, the patient had recovered from the events. The reporter assessed this case as non-serious.
Age: 34.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Loss of consciousness, Muscle tightness, Posture abnormal
Clinical narrative: This serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733850), concerns a 34-year-old, adult male patient. The patient had history of fainting after receiving an unknown vaccine (in middle school). The patient was allergic to nasal steroids. The patient did not receive any concomitant medications. On 12-Jan-2018, the patient was administered FLUVIRIN (dose: 0.5 ml, frequency: 1, route of administration: intramuscular, anatomical location: right arm (right deltoid), batch number: 179701P, expiry date: not reported). On the same day, the patient also received non-company suspect vaccine ADACEL (dose: single dose, route of administration: intramuscular, anatomical location: left arm, batch number: U5729BA, expiry date: not reported). On the same day (12-Jan-2018) after vaccination with FLUVIRIN (reported as second vaccine), the patient lost consciousness for about 5 seconds while sitting in the chair. The reporter felt that the patient's body was tightening and falling forward. The patient did not fall but was going to slump over. The reporter called emergency services and the patient's vitals were checked which found to be ok. The patient completely recovered from the events.
Age: 72.0
Sex: M
Vaccine: FLUX, TDAP
Symptoms: Injection site pain, Neck pain, Paraesthesia, Product administered to patient of inappropriate age
Clinical narrative: This serious spontaneous case, reported by a pharmacist to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 733859), concerns a 72-year-old, elderly male patient. The patient's medical history, concomitant medication and allergies were not reported. On 01-Oct-2016, the patient was administered with influenza vaccine (route of administration: intramuscular, anatomical location: right deltoid, dose, batch number, expiry date, trade name, manufacturer: not reported). On the same day (01-Oct-2016), the patient was administered with non-company suspect drug ADACEL (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number, expiry date: not reported) (case of medication error due to inappropriate age at vaccine administration). On an unspecified date, following vaccination, the patient experienced severe pain which felt like an electric shock, radiated from left shoulder area through the neck to the right shoulder. It was reported that, the pain lasted for almost one year and then started to subside. The patient's lab tests and corrective treatment was not reported. The final outcome of the events injection site pain and paraesthesia was unknown.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Syncope
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 733954), concerns an 18-year-old, adult, female patient. The patient had no relevant medical history, concomitant medication or current illness. The patient had no known drug allergy [NKDA]. On 15-Jan-2018, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml [reported as unknown], route of administration: intramuscular, anatomical location: right arm, batch number: 1720901, expiry date: not reported). On the same day after vaccination, the patient fainted. At the time of this report, the patient had recovered from the event. The reporter assessed this case as non-serious. Update received on 11-Sep-2018: Non-significant case correction performed with IRD 25-Jul-2018: In the narrative, the reporter's comment which stated the reported seriousness (non-serious) was added. The narrative was amended accordingly.
Age: 44.0
Sex: F
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: This is serious spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734093), concerns a 44-year-old adult female patient. The patient's medical history and concomitant medication were not reported. Patient's tolerance to previous vaccinations was also not reported. On an unspecified date, the patient was administered with influenza vaccine (dose: unknown, route of administration: unknown, trade name, batch number, manufacturer was not reported). On an unspecified date, few days after vaccination, the patient was diagnosed with influenza. Laboratory investigation and corrective treatment were not reported. At the time of this report, outcome of the event influenza was unknown.
Sex: F
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: This is a serious spontaneous case, reported by other non-health professional (via social media) to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734690), concerns a female patient of unspecified age. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was administered with influenza vaccine (route of administration: injection (reported as syr), dose, anatomical location, batch number, expiry date: not reported). On an unspecified date, following vaccination, the patient developed flu. Lab investigations and treatment medications were not reported. At the time of this report, the outcome of the event was unknown.
Sex: F
Vaccine: FLUX, PPV
Symptoms: Malaise
Clinical narrative: This spontaneous case, reported by a pharmacist via company representative to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 734873), concerns a female patient of an unspecified age. The patient's pertinent medical history, concurrent conditions, drug reactions and allergies were unknown. The patient's concomitant medications were not reported. On an unspecified date, the patient was administered with influenza  vaccine (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported) and non-company suspect product PNEUMOVAX 23 (dose: 1 DF [reported as 1 dose], route of administration: intramuscular, anatomical location, batch number and expiry date: not reported). On an unspecified date, after vaccination, the patient became sick and was hospitalized for an unknown duration. It was unknown, whether patient received any treatment and any laboratory investigations were performed. At the time of this report, the patient was recovering from the events. The reporter assessed the event as serious (hospitalization).
Age: 14.0
Sex: M
Vaccine: FLU3
Symptoms: Hyporesponsive to stimuli, Loss of consciousness, Pallor, Vomiting
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 735319), concerns a 14-year-old male, adolescent. The patient had no relevant medical history, concomitant medications or allergies. The patient had no current illness at the time of vaccination. On 28-Jan-2018, the patient was administered FLUVIRIN (dose: 0.5 ml, [frequency: 1], route of administration: intramuscular, anatomical location: left arm, batch number: 170104P, expiry date: not reported). On the same day, about 10 minutes after vaccination the patient was fine. But after that the patient passed out slowly when he stood up, to leave the place. The reporter and the patient's father thought that, the patient was joking. The patient reported that, he didn't know what had happened, about 1 second later when the patient revived his consciousness. The patient was very pale and started vomiting. The patient was minimally responsive. Paramedics were called and was taken to emergency room via ambulance. At the time of this report, the outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: Blood test, Chest X-ray, Computerised tomogram, Electrocardiogram, Guillain-Barre syndrome
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 735436), concerns a 54-year-old, adult male patient. The patient's current illnesses included: type 2 diabetes mellitus and gout. The patient had no known allergy. Concomitant medications included: Metformin and NEURONTIN for an unknown indication. On 01-Sep-2016, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On 28-Jan-2017, the patient was admitted to the medical center. On the same day, 4 months 28 days after the vaccine administration, the patient was diagnosed with Guillain-Barre syndrome (GBS). The patient was transferred to another hospital due to GBS. On an unspecified date during hospitalization chest X-ray, electrocardiogram (EKG), blood work, magnetic resonance imaging (twice), computed tomography (twice), spinal tap were done. On 07-Mar-2017, the patient was discharged from the hospital to home for health care. Physical therapy was advised at the time of discharge. The patient was hospitalized for the event GBS for 39 days. At the time of this report, the patient had not recovered from the event. The reporter assessed the case as serious due to hospitalization and permanent disability.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: Lumbar puncture, Nuclear magnetic resonance imaging
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 18-Jun-2018 by Seqirus from VAERS (VAERS ID: 735436), concerns a 54-year-old, adult male patient. The patient's current illnesses included: type 2 diabetes mellitus and gout. The patient had no known allergy. Concomitant medications included: Metformin and NEURONTIN for an unknown indication. On 01-Sep-2016, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On 28-Jan-2017, the patient was admitted to the medical center. On the same day, 4 months 28 days after the vaccine administration, the patient was diagnosed with Guillain-Barre syndrome (GBS). The patient was transferred to another hospital due to GBS. On an unspecified date during hospitalization chest X-ray, electrocardiogram (EKG), blood work, magnetic resonance imaging (twice), computed tomography (twice), spinal tap were done. On 07-Mar-2017, the patient was discharged from the hospital to home for health care. Physical therapy was advised at the time of discharge. The patient was hospitalized for the event GBS for 39 days. At the time of this report, the patient had not recovered from the event. The reporter assessed the case as serious due to hospitalization and permanent disability.
Age: 13.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Pallor, Syncope
Clinical narrative: This is a serious spontaneous case, reported by other health professional to VAERS and initially retrieved on 25-Jul-2018 by Seqirus from VAERS (VAERS ID: 735856), concerns a 13-year-old, male adolescent. The patient had allergic asthma. The patient was not taking any concomitant medications. On 30-Jan-2018, the patient was administered FLUVIRIN (dose: 0.5ml, frequency: 1, route of administration: unknown, anatomical location: left arm, batch number: 179904P expiry date: not reported). On the same day after vaccination, the patient fainted shortly after leaving the immunization room. The patient was brought back to the immunization room when he told his mother that he felt dizzy. The patient was given some water to drink and a couple pieces of chocolates to eat. The patient was also very pale. After resting for about 10 to 15 minutes, the patient regained his colour and was not dizzy. The patient had completely recovered from the events.
Age: 34.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Burning sensation, Chest discomfort, Dyspnoea, Headache, Hypoaesthesia
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Aug-2018 by Seqirus from VAERS (VAERS ID: 736168), concerns a 34-year-old, adult female patient. The patient had history of influenza vaccination (about 3 years ago) with adverse reactions like burning sensation down the left arm where vaccine was administered and tingling. The patient was allergic to sulfonamide antibiotics. The patient's concomitant medication included ORTHO TRI-CYCLEN for an unknown indication. On 03-Feb-2018, at around 4:50 pm, the patient was administered FLUVIRIN (dose: 0.5 ml, (frequency reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On the same day (03-Feb-2018), about 1-2 hours after vaccination, the patient experienced tingling, numbness in the middle, ring and little finger. Soon after, the patient also experienced shortness of breath and chest heaviness. Around 7 pm, the patient took BENADRYL. At around 8:45 pm, the patient called the doctor and reported the symptoms. The doctor advised to seek medical help the next day if the symptoms worsened. The patient also experienced headache and nausea, tingling feeling that moved into the palm of the left hand, increased chest tightness throughout the night leading to trouble in sleeping. On 04-Feb-2018 (in midnight of 03-Feb-2018, reported as around 12.00 am), the patient woke when tingling, numbness, burning and constricted feeling began in the left foot around the toes and sole of the foot. Subsequently, the symptoms progressed to the leg into the calf area, knee and some in thigh area. The patient's left hand started to improve by morning, however the left leg was still affected. The patient sought medical assistance at health-care walk-in care. The patient made an office visit. At the time of this report, the patient was recovering from the events (tingling and numbness) and had not recovered from other events. The reporter assessed the case as non-serious. This case (201803143) was linked to the case: 201803144 (same patient).